Moleculin Biotech INC
Brands
Hex2_Final
Hex1_v2This company sells these brands.
Moleculin is a biopharmaceutical company advancing a pipeline of product candidates for the treatment of hard-to-treat tumors and viruses. Its lead program, Annamycin, is in clinical development for acute myeloid leukemia and soft tissue sarcoma, with additional candidates WP1122, WP1066, and WP1220 in its pipeline. The company is conducting clinical trials including the MIRACLE Phase 3 study in relapsed or refractory acute myeloid leukemia and the MB-107 Phase 1B/2 study in soft tissue sarcoma with lung metastases.
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Moleculin Biotech INC | Houston | TX | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.